Nanoparticle-based technologies for retinal gene therapy
Adijanto, Jeffrey, Naash, Muna I.·2015·European Journal of Pharmaceutics and Biopharmaceutics
Cited by (106)
Items 101–106 of 106
- Nanotherapies for the prevention and treatment of diet- and genetic-related diseases: A systematic reviewDouglas W. Wilson, Mostafa Gouda, Fabien De Meester, Toru Takahashi, Ram B. Singh, Hardeep Singh Tuli, Harpal Singh Buttar · 2025 · Elsevier eBooks
- Applications of Nanofillers in the Biomedical IndustryHeba Mohamed Fahmy, Amany S. Hegazy, Abdullah M. M. Elbadry, Rana I. Soliman, Mahmoud Bassiony, Salma Mohamed Mahmoud, Hamid Ashry · 2025 · Springer eBooks
- Evolution dirigée de virus adéno-associés pour un transfert de gène efficace dans le système visuelArthur Planul · 2017
- Caractérisation des bases moléculaires de la pléiotropie CEP290 et développement d'une thérapie antisens des mutations responsables d'amaurose congénitale de Leber (ACL10)Iris Barny · 2020 · theses.fr (ABES)
- Directed evolution of adeno associated virus (AAV) for retinal gene therapyMuge Tekinsoy · 2022
- Development of Chitosan Nanoparticles for PRPF31 Gene Delivery in the Treatment of Retinitis PigmentosaMd Jobair Hossen Jony, Erik D. Moore, Alekha K. Dash, Surabhi Shukla · 2026 · Current Drug Delivery